血漿衍生藥物的全球市場(2021年∼2027年)

全球血漿衍生藥物的市場規模在預測期間內預計將以相當的年複合成長率成長。市場成長的主要因素有罕見疾病和慢性疾病的發生率增加等。

這份報告提供血漿衍生藥物市場調查，提供市場概要，市場的推動因素與阻礙因素的分析，市場機會，各產品類型，各終端用戶，各地區的市場分析，主要企業的簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

• 調查範圍
• 分析師的洞察和目前市場趨勢

第3章 市場決策要素

• 促進因素
• 阻礙因素
• 市場機會

第4章 市場細分化

• 全球血漿衍生藥物市場:各產品類型
  • 免疫球蛋白
  • 白蛋白
  • 凝血因子
  • 其他
• 全球血漿衍生藥物市場:各終端用戶
  • 醫院
  • 診療所
  • 其他

第5章 地區分析

• 北美
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 西班牙
  • 法國
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 其他亞太地區
• 其他地區

第6章 企業簡介

• Baxter International Inc.
• Biotest AG
• China Biologic Products
• CSL Ltd.
• Fusion Health Care
• GC Pharma
• Grifols S.A.
• Kedrion Biopharma
• Octapharma AG
• SK Plasma

Global Plasma-Derived Medicine Market Size, Share & Trends Analysis Report, By Product Type (Immunoglobulin, Albumins, Coagulation factor), By End-User (Hospital, Clinic, Other), Forecast (2021 - 2027)

The global plasma-derived medicine market is anticipated to grow at a considerable CAGR during the forecast period. The increasing incidence of rare and chronic diseases is a key factor driving the growth of the global plasma-derived medicine market. According to the Orphanet database, around 263-446 million persons are affected with rare and chronic diseases at any given point of time globally. This is expected the fuel the demand for the market during the forecast period.

The global plasma-derived medicine market is segmented based on product type and end-user. Based on product type, the plasma-derived medicine market is segmented into immunoglobulin, albumins, and coagulation factor. Based on end-user, the plasma-derived medicine market is segmented into hospital, clinic, and other.

Geographically, the global plasma-derived medicine market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global plasma-derived medicine market include Grifols, S.A., Octa Pharma, Antaris Pharma, CSL Ltd., and many others.

Market Segmentation

1. Global Plasma-Derived Medicine Market Research and Analysis by Product Type

2. Global Plasma-Derived Medicine Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the global plasma-derived medicine market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global plasma-derived medicine market.
• Insights about market determinants that are stimulating the global plasma-derived medicine market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. BY Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Market Determinants

• 3.1. Motivators
• 3.2. Restraints
• 3.3. Opportunities

4. Market Segmentation

• 4.1. Global Plasma-Derived Medicine Market by Product Type
  • 4.1.1. Immunoglobulin
  • 4.1.2. Albumins
  • 4.1.3. Coagulation Factor
  • 4.1.4. Other
• 4.2. Global Plasma-Derived Medicine Market by End-User
  • 4.2.1. Hospitals
  • 4.2.2. Clinics
  • 4.2.3. Other

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Baxter International Inc.
• 6.2. Biotest AG
• 6.3. China Biologic Products
• 6.4. CSL Ltd.
• 6.5. Fusion Health Care
• 6.6. GC Pharma
• 6.7. Grifols S.A.
• 6.8. Kedrion Biopharma
• 6.9. Octapharma AG
• 6.10. SK Plasma

LIST OF TABLES

• 1. GLOBAL PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
• 2. GLOBAL IMMUNOGLOBULIN MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 3. GLOBAL ALBUMINS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 4. GLOBAL COAGULATION FACTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 5. GLOBAL OTHER TYPE PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 6. GLOBAL PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 7. GLOBAL PLASMA-DERIVED MEDICINE FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 8. GLOBAL PLASMA-DERIVED MEDICINE FOR CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 9. GLOBAL PLASMA-DERIVED MEDICINE FOR OTHER END-USER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 10. GLOBAL PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
• 11. NORTH AMERICAN PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 12. NORTH AMERICAN PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
• 13. NORTH AMERICAN PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 14. EUROPEAN PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 15. EUROPEAN PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
• 16. EUROPEAN PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 17. ASIA-PACIFIC PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 18. ASIA-PACIFIC PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
• 19. ASIA-PACIFIC PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 20. REST OF THE WORLD PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
• 21. REST OF THE WORLD PLASMA-DERIVED MEDICINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL PLASMA-DERIVED MEDICINE MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (%)
• 2. GLOBAL PLASMA-DERIVED MEDICINE MARKET SHARE BY END-USER, 2020 VS 2027 (%)
• 3. GLOBAL PLASMA-DERIVED MEDICINE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
• 4. US PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 5. CANADA PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 6. UK PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 7. FRANCE PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 8. GERMANY PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 9. ITALY PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 10. SPAIN PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 11. REST OF EUROPE PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 12. INDIA PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 13. CHINA PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 14. JAPAN PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 15. REST OF ASIA-PACIFIC PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
• 16. REST OF THE WORLD PLASMA-DERIVED MEDICINE MARKET SIZE, 2020-2027 ($ MILLION)